Association between depressive symptoms and fibrosis markers: The Cardiovascular Health Study

Brain, Behavior, and Immunity

Volumn 24, Issue 2, 2010, Pages 229-235

  Kop, Willem J ^a   Kuhl, Emily A ^a   Barasch, Eddy ^b   Jenny, Nancy S ^c   Gottlieb, Stephen S ^a   Gottdiener, John S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Collagen deposition; Depression; Extra cellular matrix formation; Fibrosis; Heart failure; Inflammation; Psychological distress; Risk factors

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SCLEROPROTEIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; SEX RATIO;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COLLAGEN TYPE I; DEPRESSION; ELECTROCARDIOGRAPHY; ENDOMYOCARDIAL FIBROSIS; FATIGUE; FEMALE; FIBROSIS; HEALTH SURVEYS; HEART FAILURE; HUMANS; INFLAMMATION MEDIATORS; MALE; MULTIVARIATE ANALYSIS; PEPTIDE FRAGMENTS; PROCOLLAGEN; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 72649103765     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.09.017     Document Type: Article

References (53)

1. Andresen E.M., Malmgren J.A., Carter W.B., Patrick D.L., and Radloff L.S. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am. J. Prev. Med. 10 (1994) 77-84
2. Arbelaez J.J., Ariyo A.A., Crum R.M., Fried L.P., and Ford D.E. Depressive symptoms, inflammation, and ischemic stroke in older adults: a prospective analysis in the cardiovascular health study. J. Am. Geriatr. Soc. 55 (2007) 1825-1830
3. Barash E., Gottdiener J.S., Aurigemma G.P., Kitzman D.W., Han J., Kop W.J., et al. The association between elevated fibrosis markers and heart failure in the elderly: the Cardiovascular Health Study. Circ. Heart Fail. (2009)
4. Bovill E.G., Bild D.E., Heiss G., Kuller L.H., Lee M.H., Rock R., et al. White blood cell counts in persons aged 65 years or more from the cardiovascular health study. Correlations with baseline clinical and demographic characteristics. Am. J. Epidemiol. 143 (1996) 1107-1115
5. Cavallari L.H., Groo V.L., Momary K.M., Stamos T.D., and Vaitkus P.T. Markers of cardiac collagen turnover are similar in patients with mild and more severe symptoms of heart failure. Congest. Heart Fail. 13 (2007) 275-279
6. Cicoira M., Rossi A., Bonapace S., Zanolla L., Golia G., Franceschini L., et al. Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. J. Card Fail. 10 (2004) 403-411
7. Cushman M., Cornell E.S., Howard P.R., Bovill E.G., and Tracy R.P. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin. Chem. 41 (1995) 264-270
8. Cuspidi C., Ciulla M., and Zanchetti A. Hypertensive myocardial fibrosis. Nephrol. Dial. Transplant. 21 (2006) 20-23
9. Danner M., Kasl S.V., Abramson J.L., and Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom. Med. 65 (2003) 347-356
10. Davidson K., Jonas B.S., Dixon K.E., and Markovitz J.H. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Coronary Artery Risk Development in Young Adults. Arch. Intern. Med. 160 (2000) 1495-1500
11. de Souza R.R. Aging of myocardial collagen. Biogerontology 3 (2002) 325-335
12. Fried L.P., Borhani N.O., Enright P., Furberg C.D., Gardin J.M., Kronmal R.A., et al. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol. 1 (1991) 263-276
13. Gold P.W., Goodwin F.K., and Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1). N. Engl. J. Med. 319 (1988) 348-353
14. Gonzalez, A., Lopez, B., Ravassa, S., Beaumont, J., Arias, T., Hermida, N., et al., 2008. Biochemical markers of myocardial remodelling in hypertensive heart disease. Cardiovasc. Res., %20.
15. Gottdiener J.S., Arnold A.M., Aurigemma G.P., Polak J.F., Tracy R.P., Kitzman D.W., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J. Am. Coll. Cardiol. 35 (2000) 1628-1637
16. Izawa H., Murohara T., Nagata K., Isobe S., Asano H., Amano T., et al. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 112 (2005) 2940-2945
17. Klappacher G., Franzen P., Haab D., Mehrabi M., Binder M., Plesch K., et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am. J. Cardiol. 75 (1995) 913-918
18. Kop W.J., and Gottdiener J.S. The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom. Med. 67 (2005) 537-541
19. Kop W.J., and Cohen N. Psychoneuroimmunological pathways involved in acute coronary syndromes. In: Aider R. (Ed). Psychoneuroimmunology. fourth ed. (2007), Academic Press, Amsterdam, Boston 921-943 (Chapter 43)
20. Kop W.J., Gottdiener J.S., Tangen C.M., Fried L.P., McBurnie M.A., Walston J., et al. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am. J. Cardiol. 89 (2002) 419-424
21. Laviades C., Varo N., Fernandez J., Mayor G., Gil M.J., Monreal I., et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 98 (1998) 535-540
22. Lesperance F., and Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J. Psychosom. Res. 48 (2000) 379-391
23. Lewis M.R., Callas P.W., Jenny N.S., and Tracy R.P. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Thromb. Haemost. 86 (2001) 1495-1500
24. Lombardi R., Betocchi S., Losi M.A., Tocchetti C.G., Aversa M., Miranda M., et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 108 (2003) 1455-1460
25. Lopez B., Gonzalez A., Beaumont J., Querejeta R., Larman M., and Diez J. Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure. J. Am. Coll. Cardiol. 50 (2007) 859-867
26. Macy E.M., Hayes T.E., and Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin. Chem. 43 (1997) 52-58
27. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 19 (1995) 11-38
28. Meyer C.M., Armenian H.K., Eaton W.W., and Ford D.E. Incident hypertension associated with depression in the Baltimore Epidemiologic Catchment area follow-up study. J. Affect. Disord. 83 (2004) 127-133
29. Nicholson A., Kuper H., and Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur. Heart J. 27 (2006) 2763-2774
30. O'Brien S.M., Scully P., Fitzgerald P., Scott L.V., and Dinan T.G. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J. Psychiatr. Res. 41 (2007) 326-331
31. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Tsetsekou E., Papageorgiou C., Christodoulou G., et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur. Heart J. 25 (2004) 492-499
32. Querejeta R., Lopez B., Gonzalez A., Sanchez E., Larman M., Martinez Ubago J.L., et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110 (2004) 1263-1268
33. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977)
34. Ressler K.J., and Nemeroff C.B. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol. Psychiatry 46 (1999) 1219-1233
35. Risteli J., Niemi S., Trivedi P., Maentausta O., Mowat A.P., and Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin. Chem. 34 (1988) 715-718
36. Rozanski A., Blumenthal J.A., Davidson K.W., Saab P.G., and Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J. Am. Coll. Cardiol. 45 (2005) 637-651
37. Ruiz-Ruiz F.J., Ruiz-Laiglesia F.J., Samperiz-Legarre P., Lasierra-Diaz P., Flamarique-Pascual A., Morales-Rull J.L., et al. Propeptide of procollagen type I (PIP) and outcomes in decompensated heart failure. Eur. J. Intern. Med. 18 (2007) 129-134
38. Rutledge T., Reis V.A., Linke S.E., Greenberg B.H., and Mills P.J. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J. Am. Coll. Cardiol. 48 (2006) 1527-1537
39. Scalco A.Z., Scalco M.Z., Azul J.B., and Lotufo N.F. Hypertension and depression. Clinics 60 (2005) 241-250
40. Schulz R., Beach S.R., Ives D.G., Martire L.M., Ariyo A.A., and Kop W.J. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch. Intern. Med. 160 (2000) 1761-1768
41. Schwartzkopff B., Fassbach M., Pelzer B., Brehm M., and Strauer B.E. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy. Eur. J. Heart Fail. 4 (2002) 439-444
42. Segerstrom S.C., and Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130 (2004) 601-630
43. Suzuki Y., Ruiz-Ortega M., Lorenzo O., Ruperez M., Esteban V., and Egido J. Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35 (2003) 881-900
44. Timonen P., Magga J., Risteli J., Punnonen K., Vanninen E., Turpeinen A., et al. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy. Int. J. Cardiol. 124 (2008) 293-300
45. Tracy R.P., Bovill E.G., Yanez D., Psaty B.M., Fried L.P., Heiss G., et al. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1269-1279
46. Wang T.J., Larson M.G., Benjamin E.J., Siwik D.A., Safa R., Guo C.Y., et al. Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community. Am. Heart J. 154 (2007) 291-297
47. Weber K.T. Monitoring tissue repair and fibrosis from a distance. Circulation 96 (1997) 2488-2492
48. Weber K.T. From inflammation to fibrosis: a stiff stretch of highway. Hypertension 43 (2004) 716-719
49. Whooley M.A., de Jonge J., Vittinghoff E., Otte C., Moos R., Carney R.M., et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300 (2008) 2379-2388
50. Williams S.A., Kasl S.V., Heiat A., Abramson J.L., Krumholz H.M., and Vaccarino V. Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom. Med. 64 (2002) 6-12
51. Wulsin L.R., and Singal B.M. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom. Med. 65 (2003) 201-210
52. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214 (2008) 199-210
53. Yan L.L., Liu K., Matthews K.A., Daviglus M.L., Ferguson T.F., and Kiefe C.I. Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA 290 (2003) 2138-2148